Brief: Oncolytics Biotech Reports Net Loss For Q4 Was $19.4 Mln
05/03/2020 22:21
March 5 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® REPORTS FOURTH QUARTER AND FULL YEAR
2019
FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
* ONCOLYTICS BIOTECH INC SAYS NET LOSS FOR Q4 OF 2019 WAS
$19.4
MILLION
Source text for Eikon: ID:nCNWQT1lda
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer